Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- nutrition »
- Bovine Colostrum for Myeloma?
Bovine Colostrum for Myeloma?
Bovine Colostrum for myeloma? I don’t take bovine colostrum for my MM. I stir it into my protein shake every morning because of its nutritional properties.
I am a long-term MM survivor. I don’t believe that my body has ever fully recovered from the aggressive FDA-approved, standard-of-care therapies I underwent in, 94.’95, and ’96. I live with many late-stage chemotherapy and radiation-induced side effects, and I am trying to enhance my immune health, reduce inflammation, increase my energy, etc., through daily nutrition.
What Is Colostrum ? – Dr.Berg on Benefits of Colostrum
Email me at David.PeopleBeatingCancer@gmail.com with questions about your nutrition and supplementation.
Good luck,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Exploring the Therapeutic Potential of Bovine Colostrum for Cancer Therapies
“Abstract
Colostrum is a nutrient-rich fluid secreted by mammals shortly after birth, primarily to provide passive immunity and support early immune development in newborns. Among its various sources, bovine colostrum is the most widely used supplement due to its
- high bioavailability,
- safety profile,
- and clinically supported health benefits.
Rich in immunoglobulins, lactoferrin, growth factors, and antimicrobial peptides, bovine colostrum exhibits diverse biological activities that extend beyond neonatal health.
Recently, the rising prevalence of cancer—driven by environmental stressors such as radiation, processed foods, and chronic inflammation, as well as non-environmental hereditary factors including germline mutations, family history, and epigenetic inheritance—has fueled interest in natural adjunctive therapies.
Scientific studies have explored the anticancer potential of bovine colostrum, highlighting its ability to modulate immune responses, inhibit tumor growth, induce apoptosis in cancer cells, and reduce inflammation.
Key components including lactoferrin and proline-rich peptides have been identified as contributors to these effects. Additionally, bovine colostrum may help reduce the side effects of standard cancer treatments, such as mouth sores from chemotherapy or weakened immune systems, by helping to heal tissues and boost the body’s defenses.
While large-scale clinical studies are still needed, current findings suggest that bovine colostrum holds promise as a supportive element in integrative cancer care.
In conclusion, bovine colostrum represents a safe, bioactive-rich natural supplement with multifaceted therapeutic potential, particularly in oncology, owing to its key components such as lactoferrin, immunoglobulins, growth factors (e.g., IGF-1, TGF-β), and proline-rich polypeptides (PRPs), which contribute to its immunomodulatory, anti-inflammatory, and potential anticancer effects.
Ongoing and future research will be crucial to fully understand its mechanisms of action and establish its role in evidence-based cancer prevention and treatment strategies…
Conclusions
Colostrum is the initial milk-like secretion produced by mammals during the early postpartum period and plays a vital role in transferring passive immunity from the mother to the newborn. Rich in immunoglobulins, growth factors, antimicrobial peptides, and various bioactive molecules, colostrum is essential for the development of the neonatal immune system and intestinal health.
Beyond its primary physiological function, colostrum has attracted increasing attention in recent years for its wide-ranging therapeutic potential, supported by a growing body of preclinical and clinical research.
Cancer, defined as a group of diseases characterized by the uncontrolled proliferation, invasion, and sometimes metastasis of abnormal cells, remains a major global health burden. Despite advances in conventional treatment approaches such as surgery, chemotherapy, radiotherapy, and immunotherapy, challenges like drug resistance, systemic toxicity, and limited specificity continue to drive the need for novel and safer therapeutic alternatives.
In this context, naturally derived compounds with multi-functional biological properties are of particular interest. Several studies have demonstrated that bovine colostrum in particular contains components with potential anticancer properties.
Among these, lactoferrin has been shown to inhibit tumor initiation and progression in gastric cancer models, modulate the tumor microenvironment, and interfere with key signaling pathways involved in cancer cell proliferation and survival. Additionally, lactoferrin has been implicated in the regulation of iron metabolism, oxidative stress, and immune cell activation, all of which are relevant to tumor biology. Other colostrum-derived molecules, such as transforming growth factors and immunoglobulins, may also exert modulatory effects on cancer cell behavior.
A particularly promising area of recent research is the study of colostrum-derived extracellular vesicles, especially exosomes. These nanosized vesicles serve as natural carriers of proteins, lipids, and nucleic acids, and have been explored for their potential use in targeted drug delivery systems. In various experimental models, bovine colostrum-derived exosomes have successfully delivered therapeutic agents, resulting in enhanced anticancer activity.
Notable findings include increased cytotoxicity, reactive oxygen species (ROS) production, inhibition of cancer cell migration, and a significant reduction in tumor growth, particularly in lung cancer models. Moreover, these exosomes demonstrated superior safety profiles compared to traditional chemotherapeutics, with reduced systemic toxicity. Mechanistically, some studies have reported their involvement in downregulating KRAS expression, restoring p53 activity, and sensitizing tumors to standard drugs like paclitaxel.
As a result, these findings highlight bovine colostrum as a valuable source of bioactive compounds with the potential to contribute to cancer prevention and therapy. However, translating these experimental results into clinical applications requires further investigation.
Comprehensive mechanistic studies, rigorous clinical trials, and the development of standardized formulations are essential steps in realizing colostrum’s full therapeutic promise. As research continues to evolve, colostrum may emerge not only as a functional food supplement but also as a complementary tool in the broader landscape of cancer treatment.”
Bovine Colostrum for myeloma Bovine Colostrum for myeloma Bovine Colostrum for myeloma